These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8946431

  • 1. Vulnerability to tardive dyskinesia development in schizophrenia: an FDG-PET study of cerebral metabolism.
    Szymanski S, Gur RC, Gallacher F, Mozley LH, Gur RE.
    Neuropsychopharmacology; 1996 Dec; 15(6):567-75. PubMed ID: 8946431
    [Abstract] [Full Text] [Related]

  • 2. [Regional cerebral glucose metabolism associated with ataxic gait--an FDG-PET activation study in patients with olivopontocerebellar atrophy].
    Mishina M, Senda M, Ohyama M, Ishii K, Kitamura S, Terashi A.
    Rinsho Shinkeigaku; 1995 Nov; 35(11):1199-204. PubMed ID: 8720328
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.
    Rottenberg DA, Sidtis JJ, Strother SC, Schaper KA, Anderson JR, Nelson MJ, Price RW.
    J Nucl Med; 1996 Jul; 37(7):1133-41. PubMed ID: 8965184
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. White matter abnormalities in schizophrenia patients with tardive dyskinesia: a diffusion tensor image study.
    Bai YM, Chou KH, Lin CP, Chen IY, Li CT, Yang KC, Chou YH, Su TP.
    Schizophr Res; 2009 Apr; 109(1-3):167-81. PubMed ID: 19261444
    [Abstract] [Full Text] [Related]

  • 9. The current status of PET scanning with respect to schizophrenia.
    Sedvall G.
    Neuropsychopharmacology; 1992 Aug; 7(1):41-54. PubMed ID: 1388021
    [Abstract] [Full Text] [Related]

  • 10. Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia.
    Biver F, Goldman S, De Maertelaer V, Luxen A, Mendlewicz J, Lotstra F.
    Eur Neuropsychopharmacol; 1996 May; 6(2):141-7. PubMed ID: 8791040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia.
    Cohen RM, Semple WE, Gross M, Nordahl TE, King AC, Pickar D, Post RM.
    Neuropsychopharmacology; 1989 Dec; 2(4):241-54. PubMed ID: 2610821
    [Abstract] [Full Text] [Related]

  • 15. [18F-fluorodeoxyglucose positron emission tomography in Parkinson's disease].
    Arahata Y, Kato T, Tadokoro M, Sobue G.
    Nihon Rinsho; 1997 Jan; 55(1):222-6. PubMed ID: 9014454
    [Abstract] [Full Text] [Related]

  • 16. Positron-emission tomography in tardive dyskinesia.
    Pahl JJ, Mazziotta JC, Bartzokis G, Cummings J, Altschuler L, Mintz J, Marder SR, Phelps ME.
    J Neuropsychiatry Clin Neurosci; 1995 Jan; 7(4):457-65. PubMed ID: 8555748
    [Abstract] [Full Text] [Related]

  • 17. Quantitative analysis of PET and MRI data in normal aging and Alzheimer's disease: atrophy weighted total brain metabolism and absolute whole brain metabolism as reliable discriminators.
    Alavi A, Newberg AB, Souder E, Berlin JA.
    J Nucl Med; 1993 Oct; 34(10):1681-7. PubMed ID: 8410281
    [Abstract] [Full Text] [Related]

  • 18. Brain metabolic function in older men with chronic essential hypertension.
    Salerno JA, Grady C, Mentis M, Gonzalez-Aviles A, Wagner E, Schapiro MB, Rapoport SI.
    J Gerontol A Biol Sci Med Sci; 1995 May; 50(3):M147-54. PubMed ID: 7743400
    [Abstract] [Full Text] [Related]

  • 19. Decreased cerebral glucose metabolism in patients with brain tumors: an effect of corticosteroids.
    Fulham MJ, Brunetti A, Aloj L, Raman R, Dwyer AJ, Di Chiro G.
    J Neurosurg; 1995 Oct; 83(4):657-64. PubMed ID: 7674016
    [Abstract] [Full Text] [Related]

  • 20. Regional cerebral function determined by FDG-PET in healthy volunteers: normal patterns and changes with age.
    Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE.
    J Nucl Med; 1995 Jul; 36(7):1141-9. PubMed ID: 7790936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.